IL2 and glioblastoma: We observed similar results for IL-2– and IL-7–expanded glioblastoma patient CD8+ T cells in terms of CD107aHi degranulation, IFN-γ, and tumor-necrosis factor-alpha (TNF-α) production (Figure 6, L–N).